The Patent Trial and Appeal Board in August 2018 upheld a handful of claims in Valencell Inc.'s U.S. Patent No. 8,923,941. The U.S. Court of Appeals for the Federal Circuit last year told the board to take another look at those claims.
The PTAB said in a decision Monday that Fitbit had shown the claims are invalid because they would have been obvious based on earlier inventions.
The patent is ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.